Tarr, P E

Hachfeld, A; Atkinson, A; Stute, P; Calmy, A; Tarr, P E; Darling, K E A; Babouee Flury, B; Polli, C; Sultan-Beyer, L; Abela, I A; Aebi-Popp, K (2023). Does menopause transition influence viral suppression and adherence in Women living with HIV? Journal of acquired immune deficiency syndromes, 92(5), pp. 399-404. Wolters Kluwer Health 10.1097/QAI.0000000000003158

Kovari, H; Surial, B; Tarr, P E; Cavassini, M; Calmy, A; Schmid, P; Bernasconi, E; Rauch, A; Wandeler, G; Ledergerber, B (2021). Changes in alanine aminotransferase levels after switching from tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide (TAF) in HIV-positive people without viral hepatitis in the Swiss HIV Cohort Study. HIV medicine, 22(7), pp. 623-628. Wiley 10.1111/hiv.13106

Metral, M; Nadin, I; Locatelli, I; Tarr, P E; Calmy, A; Kovari, H; Brugger, P; Cusini, A; Gutbrod, K; Schmid, P; Schwind, M; Kunze, U; Di Benedetto, C; Pignatti, R; Du Pasquier, R; Darling, Kea; Cavassini, M (2020). How helpful are the European AIDS Clinical Society cognitive screening questions in predicting cognitive impairment in an aging, well-treated HIV-positive population? HIV medicine, 21(5), pp. 342-348. Wiley 10.1111/hiv.12828

Métral, M; Darling, Kea; Locatelli, I; Nadin, I; Santos, G; Brugger, P; Kovari, H; Cusini, Alexia; Gutbrod, Klemens; Tarr, P E; Calmy, A; Lecompte, T D; Assal, F; Monsch, A; Kunze, U; Stoeckle, M; Schwind, M; Schmid, P; Pignatti, R; Di Benedetto, C; ... (2020). The Neurocognitive Assessment in the Metabolic and Aging Cohort (NAMACO) study: baseline participant profile. HIV medicine, 21(1), pp. 30-42. Wiley 10.1111/hiv.12795

Hachfeld, Anna; Darling, K; Calmy, A; Ledergerber, B; Weber, R; Battegay, M; Wissel, K; Di Benedetto, C; Fux, C A; Tarr, P E; Kouyos, R; Ruggia, LS; Furrer, Hansjakob; Wandeler, Gilles (2019). Why do sub-Saharan Africans present late for HIV care in Switzerland? HIV medicine, 20(6), pp. 418-423. Blackwell Science 10.1111/hiv.12727

Vrouenraets, S M E; Wit, F W N M; Garcia, E Fernandez; Huber, M; Brinkman, K; Moyle, G; Domingo, P; Tarr, P E; Podzamczer, D; Ristola, M; Gatell, J M; Livrozet, J M; Furrer, H; Reiss, P; PREPARE Study Group, (2012). Longer prior exposure to zidovudine/lamivudine-containing combination antiretroviral therapy, age, and male gender are each associated with reduced subcutaneous adipose tissue. HIV clinical trials, 13(2), pp. 103-10. St. Louis, Mo.: Thomas Land Publishers

Ogredici, O; Erb, S; Langer, I; Pilo, Paola; Kerner, A; Haack, H G; Cathomas, G; Danuser, J; Pappas, G; Tarr, P E (2010). Brucellosis reactivation after 28 years. Emerging infectious diseases, 16(12), pp. 2021-2022. Atlanta, Ga.: U.S. National Center for Infectious Diseases 10.3201/eid1612.100678

Nguyen, A; Calmy, A; Schiffer, V; Bernasconi, E; Battegay, M; Opravil, M; Evison, J-M; Tarr, P E; Schmid, P; Perneger, T; Hirschel, B (2008). Lipodystrophy and weight changes: data from the Swiss HIV Cohort Study, 2000-2006. HIV medicine, 9(3), pp. 142-50. Oxford: Blackwell Science 10.1111/j.1468-1293.2007.00537.x